Selective Capture and Determination of Receptor-Binding Hemagglutinin in Influenza Vaccine Preparations Using a Coupled Receptor-Binding/RP-HPLC Assay
- 19 June 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 91 (14) , 8908-8917
Abstract
Influenza vaccine potency is determined by the quantification of immunologically active hemagglutinin capable of eliciting neutralizing antibodies upon immunization. Currently, the single radial immunodiffusion (SRID) method is the standard in vitro potency assay used for lot release of seasonal inactivated influenza vaccines. Despite the proven usage of SRID, significant limitations such as the time-consuming preparation of reagents and limited dynamic range warrant the need for the development of alternative potency assays. Such alternative approaches need to discriminate and quantify relevant hemagglutinin material, provide strain identity, and be independent of strain-specific and seasonal reagents. Herein, we present a proof of concept method that combines the capture of conformationally well-folded hemagglutinin via a sialic acid-binding step with the resolving power of reversed-phase high-performance liquid chromatography for strain identity and determination. Details of the protocol for the selective capture of receptor-binding hemagglutinin, its release from the receptor and its relative determination are presented. This approach was found to provide flexibility for the reagents to be used and was adaptable to varying strain composition of influenza vaccines. This proof-of-concept approach was developed as an antibody-independent methodology.Keywords
This publication has 47 references indexed in Scilit:
- Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strainsProceedings of the National Academy of Sciences, 2017
- A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccinePLOS Pathogens, 2017
- From Variation of Influenza Viral Proteins to Vaccine DevelopmentInternational Journal of Molecular Sciences, 2017
- Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studiesThe Lancet Infectious Diseases, 2016
- An overview of the regulation of influenza vaccines in the United StatesInfluenza and Other Respiratory Viruses, 2016
- Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort studyThe Lancet Respiratory Medicine, 2014
- Bringing influenza vaccines into the 21st centuryHuman Vaccines & Immunotherapeutics, 2013
- Pandemic influenza - including a risk assessment of H5N1Scientific and Technical Review, 2009
- Mortality benefits of influenza vaccination in elderly people: an ongoing controversyThe Lancet Infectious Diseases, 2007
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004